GENESIS Pharma

The initiative aims to strengthen and ensure a corporate governance framework that promotes ethics, transparency, and accountability across all activities of GENESIS Pharma. Specifically, it seeks to:

• Integrate high standards of ethical business conduct across all operations and relationships with stakeholders (patients, healthcare professionals, partners, suppliers).
• Ensure full transparency in decision-making processes, collaborations, and financial transactions, in accordance with the applicable regulatory and legal framework.
• Strengthen compliance and control mechanisms to effectively prevent and address potential risks or violations.
• Foster a culture of integrity and accountability among employees and management.
• Adopt international best practices in the pharmaceutical sector to enhance public trust and support the company’s sustainable growth.

Through this initiative, GENESIS Pharma reaffirms its commitment to operating as a responsible and trusted partner in the healthcare sector.

The “Corporate Governance – Ethical & Transparent Pharma” initiative addresses all key stakeholders of GENESIS Pharma, both internal and external, aiming to establish a framework of trust, ethical conduct, and transparency.

Internal Audience

• Employees (all levels: leadership, middle management, staff)

Objective: Strengthening a culture of ethics, compliance, and transparency.

• Management & Board of Directors - Responsible for strategic decision-making

Objective: Enhancing accountability and effective corporate oversight.

External Audience

• Healthcare Professionals (HCPs) (physicians, pharmacists, nurses): Ensuring ethical and transparent collaborations.
• Patients & Patient Associations: Strengthening trust and responsible corporate behavior.
• Regulatory Authorities & Institutional Bodies (EOF, Ministry of Health, European authorities): Ensuring full compliance.
• Partners & Suppliers: Promoting responsible and transparent business practices across the value chain.
• Investors / Shareholders / Business Community: Ensuring reliability, transparency, and sustainable growth.
• Society & General Public: Enhancing trust in the pharmaceutical sector.

Ongoing / long-term initiative, fully embedded in daily operations.

The initiative “Corporate Governance – Ethical & Transparent Pharma” was designed to establish a comprehensive and modern corporate governance framework, embedding high standards of ethics, transparency, and compliance across all company operations.

It was driven by the need to further strengthen stakeholder trust in a highly regulated and sensitive sector such as pharmaceuticals. GENESIS Pharma adopted a comprehensive approach, linking corporate governance not only to regulatory compliance but also to corporate culture and daily operations.

Implementation included:

• Updating and strengthening policies related to ethics, compliance, and risk management.
• Developing targeted training programs for all employees, focusing on ethical dilemmas and real-life scenarios.
• Enhancing internal control and reporting mechanisms (including whistleblowing systems).
• Integrating ESG principles and international best practices into daily operations.
• Increasing transparency in relationships with healthcare professionals, partners, and society.

Innovative / distinctive features:

• Comprehensive approach linking governance with corporate culture, beyond compliance.
• Focus on experiential learning through real-life case studies.
• Empowering employees as “ethics ambassadors”.
• Continuous evaluation and improvement through KPIs and feedback.
• Alignment with international pharmaceutical standards and best practices.

Through this initiative, GENESIS Pharma establishes a transparent, responsible, and ethical business model that strengthens sustainability and long-term value creation.

Key Implementation Tools

1. Policies & Procedures

• Code of Conduct and Business Ethics
• Compliance policies (Anti-Bribery & Anti-Corruption)
• Conflict of Interest policies
• Risk Management and Internal Control policies

2. Training & Awareness

• Mandatory training for all employees
• Targeted training for key roles
• Experiential workshops with ethical dilemmas and case studies
• Internal communication and awareness campaigns

3. Compliance & Control Mechanisms

• Internal Audit system
• External partner audits
• Monitoring and evaluation processes
• Clearly defined roles (Compliance Officer, Committees)

4. Reporting & Transparency Channels

• Confidential whistleblowing system
• Protection of anonymity and non-retaliation
• Transparent incident investigation processes

5. KPIs & Evaluation

• Monitoring compliance and ethical performance indicators
• Training participation evaluation
• Employee and stakeholder feedback
• Continuous improvement

6. Digital Tools & Infrastructure

• E-learning and compliance tracking platforms
• Policy management and approval tools
• Digital documentation and archiving

7. Governance & Culture

• Strong leadership commitment (“tone from the top”)
• Leadership role-modeling of ethical behavior
• Embedding governance principles into daily operations

The initiative is based on international standards and best practices in corporate governance and compliance, without formal partnerships with external organizations.

It was implemented internally by GENESIS Pharma, with the involvement of relevant functions (Compliance, Legal, HR, Internal Audit), ensuring alignment with the company’s strategy and culture.

The initiative remains continuously aligned with regulatory requirements and guidelines (e.g., EOF and European frameworks), although it does not constitute a formal partnership.

GENESIS Pharma:

• Continuously monitors the regulatory environment.
• Incorporates regulatory requirements into internal policies.
• Ensures full compliance and transparency.

The initiative is implemented with the active participation of all employees through training, policy application, and use of reporting mechanisms, strengthening a shared culture of integrity and accountability.

It is not based on volunteering in the traditional sense, but on responsible participation across the organization.

Internal implementation across all GENESIS Pharma operations in Greece

The initiative significantly strengthened the culture of ethics, transparency, and compliance across the organization and stakeholder relationships.

Indicative results:

• 100% employee participation in compliance and ethics training.
• Increased understanding of governance principles (via assessments and feedback).
• Strengthening trust and transparency in collaborations.
• Improved internal accountability and early reporting of issues.
• Full compliance with regulatory framework.
• Enhanced use of policies and reporting channels.

The initiative has strengthened GENESIS Pharma’s reputation as a responsible and trusted organization.

• Full employee training participation (100%).
• Strengthened integrity and accountability culture.
• Reduced operational and regulatory risks.
• Improved regulatory readiness.
• Enhanced stakeholder trust.
• Establishment of a sustainable, responsible business model.